11th Annual Report and Survey of Biopharmaceutical Manufacturing Capacity and Production - WNEM TV 5

11th Annual Report and Survey of Biopharmaceutical Manufacturing Capacity and Production

Information contained on this page is provided by an independent third-party content provider. WorldNow and this Station make no warranties or representations in connection therewith. If you have any questions or comments about this page please contact pressreleases@worldnow.com.

SOURCE Research and Markets

DUBLIN, May 20, 2014 /PRNewswire/ -- Research and Markets (http://www.researchandmarkets.com/research/9trl4k/11th_annual) has announced the addition of the "11th Annual Report and Survey of Biopharmaceutical Manufacturing Capacity and Production" report to their offering.


The 11th Annual Report and Survey of Biopharmaceutical Manufacturing Capacity and Production from BioPlan Associates, Inc., a global analysis of 238 biomanufacturers and 178 suppliers in 31 countries. The 514 page study is the industry's definitive, quantitative analysis and includes 11 years of biopharma trends and opportunities, including in-depth analysis of specific issues affecting the industry. This analysis covers the events shaping the past year, and evaluates what will shape the industry over the next five years. The study covers 12 critical areas, including: industry growth, downstream processing, single use systems, outsourcing, capacity, and quality management and much more!

This new report features trends including mAbs, biosimilars, outsourcing, disposables that are opening opportunities and challenges to the entire industry. The study also compares over time how Western Europe, the U.S., and Rest of the World biomanufacturers differ in demands for new technologies. Innovation has never been better funded and broad in scope.

Global capacity data show the impact of biosimilars, outsourcing, regulatory, as well as downstream processing and single-use devices, and how they are creating growth potential in both capacity and in the number of facilities coming on-line. Capacity utilization remains overall constant across mammalian and microbial systems, according to this year's respondents.

This will affect:

  • Overall industry growth
  • Opportunities for suppliers to the industry
  • Demand for skilled staff and better technology
  • Regulatory demands on the industry

Key Topics Covered:

CHAPTER 0: Demographics

CHAPTER 1: Introduction and Discussion

CHAPTER 2: Overview of Critical Issues in Bioprocessing

CHAPTER 3: Emerging Issues in Biopharmaceutical Manufacturing

CHAPTER 4: Capacity Utilization

CHAPTER 5: Current and Future Capacity Constraints

CHAPTER 6: Future Capacity Expansions

CHAPTER 7: Outsourcing Trends in Biopharmaceutical Manufacturing

CHAPTER 8: Disposables and Single-Use Systems in Biopharmaceutical Manufacturing

CHAPTER 9: Downstream Purification

CHAPTER 10: Quality Issues, Batch Failures, and PAT in Biopharmaceutical Manufacturing

CHAPTER 11: Hiring, Employment Growth, and Training in Biopharmaceutical

CHAPTER 12: Suppliers to Biopharmaceutical Manufacturing and Life Sciences

For more information visit http://www.researchandmarkets.com/research/9trl4k/11th_annual

Media Contact: Laura Wood, +353-1-481-1716, press@researchandmarkets.net

©2012 PR Newswire. All Rights Reserved.

Powered by WorldNow
Powered by WorldNow CNN
All content © 2014, WNEM; Saginaw, MI. (A Meredith Corporation Station) and WorldNow. All Rights Reserved.
For more information on this site, please read our Privacy Policy and Terms of Service.